A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

Starting July 7, 2025, the two highest doses of Zepbound will be available for a flat price of $499 per month, with shipments ...

Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses ...

Eli Lilly expands Zepbound access with flat-rate pricing and new vial options, supporting wider obesity treatment access ...

Telehealth firm 9amHealth has partnered with billionaire entrepreneur Mark Cuban's Cost Plus Drug Company to offer U.S.

Patients with obesity can now get Zepbound’s strongest doses for a flat rate through Lilly’s self-pay pharmacy. Eli Lilly ...

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

Mounjaro and Zepbound include the same compound tirzepatide ... is being developed both as oral and subcutaneous formulations for the treatment of obesity. Phase III studies with the subcutaneous ...

who now have another treatment option for this sleep disorder," according to a statement from the academy. But Zepbound is only for people with obesity and sleep apnea, the society noted.

A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...